Cargando…

Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease

PURPOSE: The present paper will review the impact of different therapeutic interventions on the autonomic dysfunction characterizing chronic renal failure. METHODS: We reviewed the results of the studies carried out in the last few years examining the effects of standard pharmacologic treatment, hem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seravalle, Gino, Quarti-Trevano, Fosca, Vanoli, Jennifer, Lovati, Chiara, Grassi, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292281/ https://www.ncbi.nlm.nih.gov/pubmed/33606138 http://dx.doi.org/10.1007/s10286-021-00786-6

Ejemplares similares

Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation
por: Quarti-Trevano, Fosca, et al.
Publicado: (2021)

Clinical Relevance of the Sympathetic–Vascular Interactions in Health and Disease
por: Quarti-Trevano, Fosca, et al.
Publicado: (2021)

Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure
por: Quarti‐Trevano, Fosca, et al.
Publicado: (2021)

Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement
por: Grassi, Guido, et al.
Publicado: (2021)

Endothelial, Vascular and Sympathetic Alterations as Therapeutic Targets in Chronic Heart Failure
por: Quarti-Trevano, Fosca, et al.
Publicado: (2023)

Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension
por: Dell’Oro, Raffaella, et al.
Publicado: (2023)

Sympathetic Neural Mechanisms in Hypertension: Recent Insights
por: Grassi, Guido, et al.
Publicado: (2023)

Elevated resting heart rate as independent in-hospital prognostic marker in COVID-19
por: Vanoli, Jennifer, et al.
Publicado: (2022)

Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
por: Grassi, Guido, et al.
Publicado: (2022)

Correction: Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
por: Grassi, Guido, et al.
Publicado: (2022)

Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome
por: Seravalle, Gino, et al.
Publicado: (2022)

Anthropometric Measures of Adiposity as Markers of Kidney Dysfunction: A Cross-Sectional Study
por: Vela-Bernal, Sara, et al.
Publicado: (2023)

Should White-Coat Hypertension in Diabetes Be Treated? Pro
por: Mancia, Giuseppe, et al.
Publicado: (2009)

Short- and Long-Term Reproducibility of Nighttime Blood Pressure Phenotypes and Nocturnal Blood Pressure Reduction
por: Mancia, Giuseppe, et al.
Publicado: (2021)

Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report
por: Dell’Oro, Raffaella, et al.
Publicado: (2017)

Lercanidipine in the Management of Hypertension: An Update
por: Grassi, Guido, et al.
Publicado: (2017)

Correction: New-onset aortic dilatation in the population: a quarter-century follow-up
por: Cuspidi, Cesare, et al.
Publicado: (2022)

New-onset aortic dilatation in the population: a quarter-century follow-up
por: Cuspidi, Cesare, et al.
Publicado: (2022)

Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study
por: Gronda, Edoardo, et al.
Publicado: (2014)

Sympathetic regulation of vascular function in health and disease
por: Bruno, Rosa M., et al.
Publicado: (2012)

Metronidazole-induced hepatotoxicity in a patient with xeroderma pigmentosum: A case report
por: Vanoli, Jennifer, et al.
Publicado: (2022)

Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Project
por: Russo, Elisa, et al.
Publicado: (2021)

Uric Acid, Hypertensive Phenotypes, and Organ Damage: Data from the Pamela Study
por: Grassi, Guido, et al.
Publicado: (2022)

Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets
por: Lim, Yong Jin, et al.
Publicado: (2021)

Cardiovascular Calcification in Chronic Kidney Disease—Therapeutic Opportunities
por: Himmelsbach, Anika, et al.
Publicado: (2020)

Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia
por: Aliberti, Stefano, et al.
Publicado: (2016)

Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values
por: Casiglia, Edoardo, et al.
Publicado: (2023)

The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation
por: Maloberti, Alessandro, et al.
Publicado: (2023)

Vitamin B(12) deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report
por: Vanoli, Jennifer, et al.
Publicado: (2018)

A comprehensive review of respiratory, autonomic and cardiovascular responses to intermittent hypoxia in humans
por: Puri, Shipra, et al.
Publicado: (2021)

Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes
por: Gronda, Edoardo G., et al.
Publicado: (2022)

Smads as therapeutic targets for chronic kidney disease
por: Lan, Hui Yao
Publicado: (2012)

Editorial: Autonomic regulation of cardiovascular function and implications for future therapeutic approaches
por: KenKnight, Bruce H., et al.
Publicado: (2022)

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021)

Anticancer Therapeutic Strategies Targeting p53 Aggregation
por: Ferretti, Giulia D. S., et al.
Publicado: (2022)

Modulation of vitamin D signaling is a potential therapeutic target to lower cardiovascular risk in chronic kidney disease
por: Hu, Peng, et al.
Publicado: (2011)

The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans
por: Masi, Stefano, et al.
Publicado: (2020)

Transcription Factors as Therapeutic Targets in Chronic Kidney Disease
por: Hishikawa, Akihito, et al.
Publicado: (2018)

Altered DNA methylation in kidney disease: useful markers and therapeutic targets
por: Hayashi, Kaori
Publicado: (2022)

Association between Berlin questionnaire index and blood pressure, organ damage and metabolic profilein a general population
por: Vanoli, Jennifer, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0ic0p2dcipmhcgsrgjtab15req